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Nice, France. 7-9 February 2013
Background
Some cases of cow’s milk protein allergy (CMPA)
require the use of an amino-acids based formula (AAF),
with a with a protein level higher than in standard
infant formulas. This study assessed the long term con-
sequences of an AAF-based elimination diet on the clin-
ical and biological outcome of CMPA children.
Methods
Retrospective analysis of consecutive (2004-2010)
patients diagnosed with CMPA (digestive/cutaneous/
respiratory symptoms) in a food allergy reference center
(Cohort Arsène,n°DC-2009-955), through a telephone
survey (Nov2011–Feb2012). Children were enrolled if
having adhered to dietetic recommendations, and fed
with ≥500mL/day of AAF (Neocate®) or extensive whey
hydrolysate-based formula (eWHF, Pepti-Junior®) for
≥6mo, starting either before age 6 months (AAF1,
eWHF1)), between ages >6 and 12 months (AAF2) or
after age 12 (AAF3).
Results
From a longitudinal data set of 515 children, 134
responded to enrolment criteria, 102 fed with AAF and
32 fed with eWHF. At survey, BMI (percentiles) in
males was in the normal range and identical whether
fed by AAF or eWHF. In females, BMI was significantly
lower in AAF1vs eWHF1 (p 0.04). Ferritin and hemo-
globin levels were within the normal range in all groups.
Conclusion
This study suggests that feeding CMPA children
with>500 mL/day of AAF for >15 mo showed a good
nutritional outcome with an appropriate anthropo-
morphic parameters and iron status.
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Table 1
Age at survey (months) (Mean, SD) AAF1(n=41)66.02±26.5 eHWF1(n=20)86.55±24 AAF2(n=42)62.4±34.3 AAF3(n=20)73.5±28.7
BMI percentile in males at survey: (Mean, SD) 42.85±28.79 44.17±30.07 42.73±29.37 31±25.09
BMI percentile in females at survey (Mean, SD) 31.91±38 64.16±26.07 31.54±24.95 33.85±22.68
Ferritin in males/females (Mean, SD) 26.7±13.6/27±17 11.98±0.8/12.6±0.4 11.64±0.6/12.7±0.4 30.6±14.1/26.5±0.5
Hemoglobin in males/females (Mean, SD) 31.7±9.8/35±8.6 11.05±0.55/35.12±30.3 12.38±0.75/11.6±0.6 34.3±12.28/11.36±1.8
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